4098 results about "Pharmacy" patented technology

Abstract of the Disclosure The invention presents a networked system for identifying an individual, communicating information to the individual, and remotely monitoring the individual. The system includes a remotely programmable apparatus that occasionally connects to a server via a communication network such as the Internet. The remotely programmable apparatus interacts with the individual in accordance with a script program received from the server Among other capabilities, the script program may instruct the remotely programmable apparatus to identify the individual, to communicate information to the individual, to communicate queries to the individual, to receive responses to the queries, and to transmit information identifying the individual and the responses from the remotely programmable apparatus to the server. Information identifying the individual may be obtained via a biometrics sensor, a data card, a remote monitoring device, or the interception of data from a separate information system. The information identifying the individual may be used by either or both the server system and remotely programmable apparatus for security, customization and other purposes. As the present invention has multi-user capabilities, it can be used in a public place, such as a pharmacy or health care clinic. The multi-user capabilities also allow collection and tracking of user data for the healthcare industry.

A patient monitor system implemented by a service provider for users via recording a patients analytes measurements by an attenuated total reflection (ATR) infrared total spectroscopy method. The system comprises an input module that provides a non-invasive method in measuring analytes in a patient, such as a measurement of the glucose level and other blood analytes. The measurement is shared among a plurality of output devices such as computers, personal digital assistants (PDAs), cellular phones, and pagers that are stationed or held by various users such as doctors, patients, researchers, pharmacies, labs, and health insurers. In addition behavioral attributes are recorded and correlated with the analytes measurements to generate a profile. The profile is selectively sent to output devices based on the user profile corresponding to the output device. Also, access to the profile is monitored by a security module that encrypts the profile to prevent access by un-authorized users.

<heading lvl="0">Abstract of Disclosure< / heading> An integrated suite of services for consumers, service providers and manufacturers in the pharmaceutical industry is disclosed. The present invention utilizes one or more of the NCPDP standard formats and adopts the switch for an integrated system of, for example, instant adjudication of prescriptions, consumer data warehousing and / or incentive rewards for the consumer. A participating consumer with one card, can instantly purchase pharmaceuticals and charge the transaction to a credit card and earn and apply savings dollars redeemable for pharmaceutical purchases. For a participating service provider, instant adjudication and instant validation of consumer eligibility can be performed. Moreover, a service provider may receive messages related to the patient's medications. Significantly, data is recorded for consumers even when consumers make the pharmaceutical purchase with cash. The system includes a unique card issued to participating consumers. The card is adapted to encode conventional credit or debit card information specific to the participating consumer so that the consumer can consummate a transaction for the purchase of pharmaceuticals without possession of an additional credit card. The system further includes a host processor coupled to the point of sale at the service provider through a leased line or public switch network or the like. When a customer performs a pharmaceutical transaction at the point of sale of the service provider, the host processor coordinates any benefits and data with other prescription benefit management systems through messages transmitted and received from any primary or secondary carrier systems. The host processor further is adapted to facilitate real-time adjudication of claims and checks for any dangerous drug-to-drug interactions. The host processor additionally facilitates any financial processing including the accumulation and redemption of any bonus dollars earned by the consumer. Furthermore, since the card used by the consumer can be encoded with credit or debit card information, the host processor determines the desired payment method and performs the actual financial transaction. Even if the transaction at the point of sale is a cash purchase, the consumer may desire to use his unique card for the accrual of bonus dollars. Therefore, data concerning the transaction (i.e., pharmacy number, prescription number, etc.) can be recorded even for transactions conducted with cash.

A system and methods is described for providing unified and secure centralizing information management to permit interoperability of disparate stakeholders in the healthcare industry access and update information under a common scheme thereby creating a more efficient delivery system for all the stakeholders such as patients, doctors, clinics, hospitals, insurance companies, pharmacies and related healthcare entities.

A system and method for monitoring, managing and controlling medication delivery from a central location is provided. A central computer displays medication orders and ongoing medication administrations for a health care facility. The central computer checks medication delivery against a database of medication administration guidelines, including guidelines for medication interactions with other medications and with patient conditions and provides an indication of any detected incompatibilities. A clinician at the central location may adjust the medication administration parameters in response to detected incompatibilities and communicate with a caregiver at the point of care to provide decision support. In one embodiment, the central location is a pharmacy at the healthcare facility.

In the present invention, the user will sign onto a system, utilizing a biometrics authentication or identification procedure. Once authentication and identification takes place, local, regional, and centralized medical databases can be automatically queried using the identification-specific biometrics signature. All data intrinsic to the medical procedure or examination being performed will be automatically tagged and downloaded into that specific patient's electronic medical database. At the same time, that patient's medical database is queried to provide all historical data relevant to the medical examination or procedure being performed to assist with planning, protocol, and analysis of the data being collected. The biometrics authentication can be performed at patient intake, at an imaging device, at a pharmacy, or in the operating room, to ensure that the personnel and the patient are correctly identified before any procedure is performed or drug administered.

A system and method for prescription therapy management and compliance are provided. The system framework integrates primary databases from pharmacies, pharmacy benefit managers (PBMs), health plans, and EHR providers with a secondary database system, user interface, and wireless messaging platform, in order to extract and aggregate user-specific prescription data and make it available to users through a personalized account and as a part of a wireless prescription reminder service. The system helps users access, aggregate, manage, update, automate, and schedule the prescriptions they are currently taking. Users receive real-time wireless prescription dosing reminders based on their prescribed drug, dosage, and other indications, tailored to each individual's daily schedule. These wireless dosing reminders (i) include additional instructional content such as pill images, compliance tools, and Web or WAP drug links, (ii) are automatically scheduled and transmitted based on the user's prescription source data, in conjunction with selections indicated on their personal account, and (iii) are transmitted via SMS, EMS, MMS, WAP, email, and other formats to the user's mobile phone, PDA, or other wireless device. The integrated interface and secondary database system enable a number of additional system features which focus on compliance and management of the underlying source prescription data.

A method of allocating resources includes scheduling jobs from among a plurality of resources of a work-producing system. The work producing system is a pharmacy. The method includes the steps of sorting, in a predetermined order, available resources to be utilized in the pharmacy by a last task assignment, a number of tasks performable, rate per task, and / or cost per hour, and determining one or more queues responsive to the sorting. The method also includes the step of normalizing the queue by dividing a current task queue by an average rate of the available resources for each task in the current task queue. The method also includes the step of assigning the available resources to one or more tasks with a predetermined normalized queue, subject to at least one task constraint.

An inventory control and prescription management and dispensing system including a dispensing vault for storing and dispensing prescriptions, the dispensing vault in communication with a central computer system that, in turn, communicates with prescription providers, insurance companies, and other third parties; the dispensing vault including robotic means for randomly accessing pre-filled prescriptions within the vault, with the vault further including RFID, bar code, and other means for verifying the content and internal location of pre-filled prescriptions; a customer interface that uses customer biometrics to ID a customer to ensure that prescriptions are only dispensed to the correct person; a patient registration system in communication with the central computer system for collecting insurance, doctor, biometric, and other information to facilitate transactions; a labeling system for labeling pre-filled prescriptions with customer specific information upon dispensing; transport container that integrate into the dispensing vault and provide secure transportation from a pharmaceutical manufacturer or repackager to the dispensing vault, security provided through RFID tags which communicate with the central computer to verify that the transport container contains the correct formulary and that the integrity of the container (temperature range, time in transit, tampering) has not been compromised; a payment system integral to the dispensing vault that is in communication with third party banks and pharmacy billing management systems, credit agencies and the central computer; a verification system for ensuring that pre-filled bottles received from the manufacturer (before they are placed into the storage locations inside the vault) have not had their integrity compromised, with this system evaluating each container's weight, size, moisture content, shape, velocity change, color, pattern, and physical integrity (all comparisons made against standards stored in the central computer).

An intravaginal drug delivery device comprises a device body comprising a hydrophobic carrier material having at least one channel defining at least one opening to the exterior of said device body, said at least one channel being adapted to receive at least one drug-containing insert; at least one drug-containing insert positioned in said at least one channel, said drug-containing insert capable of releasing a pharmaceutically effective amount of at least one drug suitable for intravaginal administration and containing about 1% to about 70% of at least one water-soluble release enhancer, both the drug and the water-soluble release enhancer dispersed in an insert carrier material; wherein said hydrophobic carrier material and said insert carrier material may be the same or different; and wherein said at least one drug-containing insert is exposed on said exterior of said device body when said intravaginal drug delivery device is in use.

The invention describes a health product additive and preparation for sots or hepatitis B pathogen carriers By adding medicinal fungus fermentation liquor as additive and using effective components and fine powder extracted from plants and herbal medicines by solvent as adjuvant, the health product can be made into forms of effervescent tablet, buccal tablet, chewable tablet, oral taken tablet, candy, chocolate, chewing gum, oral liquid, particle, soluble granules, capsule, aerosol, liquid beverage and solid beverage. The product can relieve alcohol effect, nourish stomach, protect liver, and help to remit hepatitis B virus and hepatitis liver cancer patient condition, achieves a quite important effect for protecting the health of the sots or hepatitis B pathogen carriers in daily or social occasions. The invention provides a good idea to the utilization of the large amount of active fermentation liquid generated with the thallus pharmacy in the medicinal fungus fermentation industries, and also provides a effective approach for increasing the utilization value of the large amount of wild plant resources such as wild jujube and haw widely distributed in the north areas.

A system and method for managing medication orders, including verbal orders and changes to those orders, is described. A server receives mediation orders from a pharmacy and communicates those orders to an infusion pump. The infusion pump communicates status messages to the server and the server compares the status messages to the medication orders to determine if the there were any changes to the order, or if a medication was administered absent a medication order. The server assigns a new order identification number to the status message if needed. The system may also reconcile original medication orders with information associated with a new order identification number and stores the information in the eMAR of a patient.

The invention relates to new use of levo-oxiracetam in pharmaceutical field, and in particular relates to application of levo-oxiracetam in preparation of a medicine for treating memory and intelligence disturbance. The experiment result shows that the levo-oxiracetam is a main active ingredient for playing efficacy in oxiracetam, the clinical dosage can be greatly reduced by singly using the levo-oxiracetam, and the potential toxic and side effect is reduced. According to the invention, the levo-oxiracetam is a single active ingredient, the raw material purity is greater than 99.5% so as to effectively avoid the toxicity risk caused by other impurities in the medicine, the pharmacy is safer, the medicine quality is more controllable, and the curative effect is more precise.

A method is disclosed whereby consumers enrolled in a prescription benefit plan can obtain prescription medication fulfillment at any participating pharmacy of their choice, regardless of whether the fulfillment is by a retail pharmacy or a mail order pharmacy, and whether the quantity of medication prescribed is for administration over a short period (acute care) or a prolonged period (maintenance). The plan of this invention operates by having the plan manager substantially equalize the financial effects of the discounts and services fees allowed to participating pharmacies such that both retail and mail order pharmacies are compensated in a manner which encourages them to accept all consumers and fill all prescriptions. Compensation is preferably adjusted periodically by the manager to retain pharmacy incentives. Consumers obtain choice of pharmacies, plan payers have pleased employees and members and pharmacies obtain income from the entire spectrum of consumers.

An automated personal pill dispenser has at least two chambers, each for holding a supply of pills. A feed mechanism is associated with each of the chambers and is operable selectively to feed an incremental number of pills from a respective one of the chambers. A programmable controller is coupled to control and operate the feed mechanism to dispense pills from the chambers. The controller has a timer, a memory and an input means. The controller is operable programmably, by the user and / or by remote input from a smart card, PDA or network, for example with access to data from a pharmacy including instructions and warnings. The programming presets at least one of a time and a number of pills to be dispensed from each of said chambers. The controller operates an alarm to alert the user and operates the feed mechanism to feed pills from the chambers at the preset time and number, also detecting the user's access to obtain the dispensed pills.

A system is provided for delivery and monitoring the administration of controlled substances which includes one or more databases including a national database of controlled substance users, a database including physician / pharmacy information, a controlled substance delivery device and a docking station for use together with a network and software for communication between the various components of the system.

A pharmaceutical administrative system with a pharmacy and a service center network for preparing and dispensing medication. The pharmacy network prepares orders for medication from various customers for various patients. By retrieving information from a global database in the service center network, the pharmacy network conveys patient, customer and formulary information to users of the pharmacy network. Also, the pharmacy network prepares medication specific labels to identify and verify the contents of the medication. Furthermore, the pharmacy network provides additional safeguards and information, including balancing orders and displaying and / or generating hardcopies of solubility curves, to a health care provider using the pharmacy network with the additional ability to customize the medication.

This invention is a system and method for a matching system that cross-references patients anonymously with doctors and pharmacies. The invention uses patient-unique biometrics, such as fingerprinting, retinal scanning, or another such unique identifier, for patient identification and verification without revealing a patient's name or other personal information. The system tracks patient prescriptions and produces alerts to indicate potential problems, such as drug interactions or possible fraudulent behavior. The system utilizes the biometric data of the prescribing physician as authorization of the prescription. The system can produce a traceable paper trail, for investigation or prosecution, and protects the medical industry, patients, and the public from the consequences of doctor shopping.

A prescription drug storage and dispensing arrangement allows prescriptions stored, as they are filled, in a cabinet for customer pickup. The prescriptions are placed into receptacles such as pharmacy envelopes and placed on carriers, e.g., hanger bars, that are transported on a conveyor within the cabinet. The conveyor brings one carrier at a time to an access opening for loading or retrieving of a pharmacy envelope. In one embodiment the hanger bars are rods with spaced annular recesses defining bag positions. Scissors-action arms may be used to suspend the hanger rods from the conveyor webs. The identity of each pharmacy envelope and the location of the respective bar on said conveyor and the bag position are stored in a computer, with information identifying the customer order. When the customer arrives to pick up the prescription, the customer data is entered and the conveyor automatically moves to position the respective hanger bar at the access opening. A laser and mirror arrangement can be used to identify the specific bag location. This arrangement has applications for other customer orders or merchandise. Another embodiment has carrier trays for dispensing punch cards.

A point-of-care touch / click entry system can be used to replace and / or augment standard dictation transcription models in medical record systems (which comprise institution-centric data). Key word entry can better standardized medical record display, can be linked directly to diagnostic and billing codes to automate billing thus decreasing payers claims of fraud and can be used to insert data variables directly into relational databases to improve outcome analysis. In total the “clinical operating system (COS) and clinical information system (CIS) can quickly and accurately produce “longitudinal” lifetime medical records (which comprise patient-centric data). The longitudinal medical record can be used in accordance with medical record systems to connect patients, providers, pharmacies, clinics, hospitals, payers, and producers through a secure private network that operates in real-time at the point of care on-line or off-line.

A prescription pharmacy bottle comprises a container and a label. The container includes a generally planar front portion having a generally rectangular shape and a generally planar back portion spaced from the front portion. The back portion has a generally rectangular shape and generally faces away in an opposite direction from the front portion. The label is secured to the container bearing printed matter related to a medication and includes a front portion secured on the front portion of the container and a back portion secured on the back portion of the container.

A comprehensive patient data assessment system and method for use in generating, tracking and analyzing medical data related to healthcare administered by a group of physicians to a specified patient population. The system is operative to track data related to the claims history, case management, pharmacy data, and lab tests / results for each patient treated by each patient's primary care physician preferably through electronic medical records that are accessible over a computer network. The system is operative to generate data indicative of the utilization of healthcare resources utilized to treat each patient within the patient population, as well as ensure that each primary care physician utilizes appropriate codes for each diagnosis and procedure / test administered to each patient. The system further provides for categorization of patients afflicted with chronic conditions that require high-cost care. The systems are exceptionally effective in conserving medical resources, ensuring uniformity in administering healthcare, and achieving optimal patient outcomes.

Methods and systems are related to the payment of pharmacy benefits under an insurance policy. The system includes pharmacies, a real-time claims processing adjudication component, an information component and a claims processing or billing component. When a qualified patient submits a prescription to a participating pharmacy, the pharmacy collects identifying information from the patient and conveys a request to the real-time claims adjudication component, which screens the request for a match to data already loaded in the system and conveys a notification of acceptance or error to the pharmacy. The real-time claims adjudication component compiles records of the approved claims and the claims processing component processes the claims, bills third party payors and generates periodic files detailing payments owed to pharmacies. Funds are then made available to the pharmacy. The pharmacy may obtain the funds by initiating a transfer, such as a charge placed on a card issued by the system.

The present invention is a system and method for anticipating potential Adverse Drug Events (ADE) in a patient's medication regimen by integrating data typically located in laboratory and pharmacy information systems and filtering the data using predefined criteria. The present invention includes a system for anticipating a possible ADE through the use of a search engine that compares integrated data from laboratory and pharmacy information systems and compares it to predefined ADE rules defining normal ranges for a particular laboratory test. If an abnormal test value is received and a drug in the patient's medication regimen satisfies a drug included in an ADE rule then an alert procedure is triggered which allows for a period of time wherein the patient's lab and pharmacy data is monitored in order to determine if a proper corrective action is undertaken, and if no corrective action or an improper corrective action is taken within that period of time, the healthcare provider is warned of a potential ADE.

Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.